Nitin Sood is Chief Commercial Officer, MRD of Adaptive Biotechnologies Corp. Currently has a direct ownership of 214,808 shares of ADPT, which is worth approximately $760,420. The most recent transaction as insider was on Aug 08, 2023, when has been sold 10,550 shares (Common Stock) at a price of $6.54 per share, resulting in proceeds of $68,997. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 215K
0% 3M change
7.01% 12M change
Total Value Held $760,420

NITIN SOOD Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 08 2023
SELL
Open market or private sale
$68,997 $6.54 p/Share
10,550 Reduced 4.68%
214,808 Common Stock
Aug 07 2023
SELL
Open market or private sale
$38,320 $6.78 p/Share
5,652 Reduced 2.45%
225,358 Common Stock
Mar 07 2023
SELL
Open market or private sale
$84,391 $8.6 p/Share
9,813 Reduced 4.07%
231,010 Common Stock
Mar 06 2023
SELL
Open market or private sale
$57,084 $8.57 p/Share
6,661 Reduced 2.69%
240,823 Common Stock
Mar 06 2023
BUY
Grant, award, or other acquisition
-
132,979 Added 34.95%
247,484 Common Stock
Nov 01 2022
SELL
Open market or private sale
$248,528 $8.0 p/Share
31,066 Reduced 21.34%
114,505 Common Stock
Aug 05 2022
SELL
Open market or private sale
$192,589 $10.98 p/Share
17,540 Reduced 10.75%
145,571 Common Stock
Mar 04 2022
BUY
Grant, award, or other acquisition
-
65,898 Added 28.78%
163,111 Common Stock
Aug 16 2021
BUY
Grant, award, or other acquisition
-
97,213 Added 50.0%
97,213 Common Stock
NS

Nitin Sood

Chief Commercial Officer, MRD
Seattle, WA

Track Institutional and Insider Activities on ADPT

Follow Adaptive Biotechnologies Corp and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADPT shares.

Notify only if

Insider Trading

Get notified when an Adaptive Biotechnologies Corp insider buys or sells ADPT shares.

Notify only if

News

Receive news related to Adaptive Biotechnologies Corp

Track Activities on ADPT